5Kokhanenko NIU, Ignashov AM, Varga EV, et al. Role of the tumor markers CA19-9 and carcinoembryonic antigen (CEA) in diasnosis , treatment and prognosis of pancroatic cancer. Vopr Onkol1,2001,47(3) : 294. 被引量：1
2Hayashi N, Nakamori S,Okami J,et al. Asscciation between expression levels of CA 19-9 and N-acetylglucosaminee-beta; 1,3-galactosyltransferase 5gene in human pancreatic cancer tissun[ J ]. Pathobiology, 2003,71 ( 1 ): 26～34. 被引量：1
3Macchia V, Gargiulo M. Cyclic AMP-dependent secretion of CA 19-9 by LS174T human colon carcinoma cells[ J]. Oncol Rep, 2002, 9 (2): 387 ～391. 被引量：1
5Kim HJ,Lee KT, Kim SH,et al. Differential diagnosis of intrahepatic bile duct dilatation without demonstrable mass on ultrasonography or CT: Benign versus malignancy [ J ]. J Gastroenterol Hepatol.2003, 18 ( 11 ): 1 287 ～1292. 被引量：1
6Kokhanenko NIU, Ignashov AM, Varga EV, et al. Role of the tumor markers CA 19-9 and carcinoembryonic antigen(CEA)in diagnosis, treatment and prognosis of pancreatic cancer[J].Vopr 0nkol.2001,47(3) :294～ 297. 被引量：1
7Carpelan-Holmstrom M,Louhimo J,Stmman UH,et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers[J].Anticancer Res,2002,22(4) :2 311 ～ 2 316. 被引量：1
8Duraker N, Cekik AN.The prognostic significance of properative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA [J].J Sug Oncol,2001,76(4) :266～ 271. 被引量：1
9Oremek GM,Sapoutzis N,Lorenz M.Phospholipds,tumour marker and beta-CrossLaps in diagnosis of gastric carcinoma[J]. Anticancer Res, 2003,23(2A) :859 ～ 863. 被引量：1
10Yamamoto H, Miyake Y,Noura S.Tumor markers for colorectal cancer[J]. Gan To Kagaku Ryoho,2001,28(9): 1 299 ～ 1 305. 被引量：1
